{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:22:05Z","timestamp":1783524125675,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bryn Pharma LLC","award":["N.A"],"award-info":[{"award-number":["N.A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Histamine release and vasodilation during an allergic reaction can alter the pharmacokinetics of drugs administered via the intranasal (IN) route. The current study evaluated the effects of histamine-induced nasal congestion on epinephrine pharmacokinetics and heart rate changes after IN epinephrine.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Dogs received 5% histamine or saline IN followed by 4\u2009mg epinephrine IN. Nasal restriction pressure, epinephrine concentration, and heart rate were assessed. Maximum concentration (C<jats:sub>max<\/jats:sub>), area under plasma concentration-time curve from 1 to 90\u2009min (AUC<jats:sub>1\u201390<\/jats:sub>), and time to reach C<jats:sub>max<\/jats:sub> (T<jats:sub>max<\/jats:sub>) were measured. Clinical observations were documented.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In the 12 dogs in this study, nasal congestion occurred at 5\u201310\u2009min after IN histamine administration versus no nasal congestion after IN saline. After administration of IN epinephrine, IN histamine-mediated nasal congestion was significantly reduced to baseline levels at 60, 80, and 100\u2009min. There were no significant differences in C<jats:sub>max<\/jats:sub> and AUC<jats:sub>1\u201390<\/jats:sub> between histamine and saline groups after IN epinephrine delivery (3.5 vs 1.7\u2009ng\/mL, <jats:italic>p<\/jats:italic>\u2009=\u20090.06, and 117 vs 59\u2009ng\/mL*minutes, <jats:italic>p<\/jats:italic>\u2009=\u20090.09, respectively). After receiving IN epinephrine, the histamine group had a significantly lower T<jats:sub>max<\/jats:sub> versus the saline group (6 vs 70\u2009min, respectively; <jats:italic>p<\/jats:italic>\u2009=\u20090.02). Following IN epinephrine administration, the histamine group showed rapidly increased heart rate at 5\u2009min, while there was a delayed increase in heart rate (occurring 30\u201360\u2009min after administration) in the saline group. Clinical observations included salivation and emesis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>IN histamine led to more rapid epinephrine absorption and immediately increased heart rate compared with IN saline. IN epinephrine decreased histamine-induced nasal congestion.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12931-020-01343-x","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:07:53Z","timestamp":1585908473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Intranasal epinephrine effects on epinephrine pharmacokinetics and heart rate in a nasal congestion canine model"],"prefix":"10.1186","volume":"21","author":[{"given":"Richard","family":"Tuttle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Slanczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Barre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond","family":"Slade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Croutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Robben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zack","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Dretchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"1343_CR1","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jaci.2013.10.029","volume":"133","author":"L Ma","year":"2014","unstructured":"Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133:1075\u201383.","journal-title":"J Allergy Clin Immunol"},{"key":"1343_CR2","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.jaci.2015.10.027","volume":"137","author":"AN Jeppesen","year":"2016","unstructured":"Jeppesen AN, Christiansen CF, Froslev T, Sorensen HT. Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012. J Allergy Clin Immunol. 2016;137:1143\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"1343_CR3","doi-asserted-by":"publisher","first-page":"e5750","DOI":"10.1097\/MD.0000000000005750","volume":"96","author":"MS Yang","year":"2017","unstructured":"Yang MS, Kim JY, Kim BK, Park HW, Cho SH, Min KU, et al. True rise in anaphylaxis incidence: epidemiologic study based on a national health insurance database. Medicine (Baltimore). 2017;96:e5750.","journal-title":"Medicine (Baltimore)"},{"key":"1343_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","volume":"8","author":"FE Simons","year":"2015","unstructured":"Simons FE, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M, Tanno LK, et al. 2015 update of the evidence base: world allergy organization anaphylaxis guidelines. World Allergy Organ J. 2015;8:32.","journal-title":"World Allergy Organ J"},{"key":"1343_CR5","doi-asserted-by":"publisher","first-page":"e20164006","DOI":"10.1542\/peds.2016-4006","volume":"139","author":"SH Sicherer","year":"2017","unstructured":"Sicherer SH, Simons FER. Epinephrine for first-aid management of anaphylaxis. Pediatrics. 2017;139:e20164006.","journal-title":"Pediatrics"},{"key":"1343_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaip.2014.07.004","volume":"3","author":"JT Fleming","year":"2015","unstructured":"Fleming JT, Clark S, Camargo CA Jr, Rudders SA. Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. J Allergy Clin Immunol Pract. 2015;3:57\u201362.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1343_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.5811\/westjem.2018.4.37453","volume":"19","author":"RA Lindor","year":"2018","unstructured":"Lindor RA, McMahon EM, Wood JP, Sadosty AT, Boie ET, Campbell RL. Anaphylaxis-related malpractice lawsuits. West J Emerg Med. 2018;19:693\u2013700.","journal-title":"West J Emerg Med"},{"key":"1343_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/DHPS.S121733","volume":"9","author":"LS Posner","year":"2017","unstructured":"Posner LS, Camargo CA Jr. Update on the usage and safety of epinephrine auto-injectors, 2017. Drug Healthc Patient Saf. 2017;9:9\u201318.","journal-title":"Drug Healthc Patient Saf"},{"key":"1343_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2500\/aap.2014.34.3763","volume":"35","author":"JA Bellanti","year":"2014","unstructured":"Bellanti JA, Settipane RA. Quality of life issues ranging from the burden of ocular and nasal allergies to the anxiety associated with having to carry self-injectable epinephrine for insect sting allergy. Allergy Asthma Proc. 2014;35:195\u20136.","journal-title":"Allergy Asthma Proc"},{"key":"1343_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jaip.2016.12.016","volume":"5","author":"E Shemesh","year":"2017","unstructured":"Shemesh E, D'Urso C, Knight C, Rubes M, Picerno KM, Posillico AM, et al. Food-allergic adolescents at risk for anaphylaxis: a randomized controlled study of supervised injection to improve comfort with epinephrine self-injection. J Allergy Clin Immunol Pract. 2017;5:391\u20137 e394.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1343_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13223-016-0110-8","volume":"12","author":"S Dreborg","year":"2016","unstructured":"Dreborg S, Wen X, Kim L, Tsai G, Nevis I, Potts R, et al. Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy? Allergy Asthma Clin Immunol. 2016;12:11.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"1343_CR12","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.jaip.2019.03.021","volume":"7","author":"J Portnoy","year":"2019","unstructured":"Portnoy J, Wade RL, Kessler C. Patient carrying time, confidence, and training with epinephrine autoinjectors: the RACE survey. J Allergy Clin Immunol Pract. 2019;7:2252\u201361.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1343_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s11739-015-1255-z","volume":"10","author":"E Ridolo","year":"2015","unstructured":"Ridolo E, Montagni M, Bonzano L, Savi E, Peveri S, Costantino MT, et al. How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients. Intern Emerg Med. 2015;10:937\u201341.","journal-title":"Intern Emerg Med"},{"key":"1343_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","volume":"143","author":"F Erdo","year":"2018","unstructured":"Erdo F, Bors LA, Farkas D, Bajza A, Gizurarson S. Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res Bull. 2018;143:155\u201370.","journal-title":"Brain Res Bull"},{"key":"1343_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.18433\/J3NC79","volume":"12","author":"A Pires","year":"2009","unstructured":"Pires A, Fortuna A, Alves G, Falcao A. Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci. 2009;12:288\u2013311.","journal-title":"J Pharm Pharm Sci"},{"key":"1343_CR16","doi-asserted-by":"publisher","first-page":"9563","DOI":"10.1038\/s41598-019-46032-y","volume":"9","author":"S Al Harthi","year":"2019","unstructured":"Al Harthi S, Alavi SE, Radwan MA, El Khatib MM, AlSarra IA. Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer's disease. Sci Rep. 2019;9:9563.","journal-title":"Sci Rep"},{"key":"1343_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yebeh.2017.02.023","volume":"71","author":"AK Berg","year":"2017","unstructured":"Berg AK, Myrvik MJ, Van Ess PJ. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: randomized study in healthy geriatric and non-geriatric adults. Epilepsy Behav. 2017;71:51\u20139.","journal-title":"Epilepsy Behav"},{"key":"1343_CR18","doi-asserted-by":"publisher","first-page":"e1914977","DOI":"10.1001\/jamanetworkopen.2019.14977","volume":"2","author":"P Dietze","year":"2019","unstructured":"Dietze P, Jauncey M, Salmon A, Mohebbi M, Latimer J, van Beek I, et al. Effect of intranasal vs intramuscular naloxone on opioid overdose: a randomized clinical trial. JAMA Netw Open. 2019;2:e1914977.","journal-title":"JAMA Netw Open"},{"key":"1343_CR19","doi-asserted-by":"publisher","first-page":"7276021","DOI":"10.1155\/2018\/7276021","volume":"2018","author":"LR Webster","year":"2018","unstructured":"Webster LR, Pantaleon C, Iverson M, Smith MD, Kinzler ER, Aigner S. Intranasal pharmacokinetics of morphine ARER, a novel abuse-deterrent formulation: results from a randomized, double-blind, four-way crossover study in nondependent, opioid-experienced subjects. Pain Res Manag. 2018;2018:7276021.","journal-title":"Pain Res Manag"},{"key":"1343_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1710-1492-10-6","volume":"10","author":"R Bayat","year":"2014","unstructured":"Bayat R, Borici-Mazi R. A case of anaphylaxis to peppermint. Allergy Asthma Clin Immunol. 2014;10:6.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"1343_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13223-018-0303-4","volume":"14","author":"L Soller","year":"2018","unstructured":"Soller L, La Vieille S, Chan ES. First reported case in Canada of anaphylaxis to lupine in a child with peanut allergy. Allergy Asthma Clin Immunol. 2018;14:64.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"1343_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/IJGM.S8088","volume":"3","author":"RM Naclerio","year":"2010","unstructured":"Naclerio RM, Bachert C, Baraniuk JN. Pathophysiology of nasal congestion. Int J Gen Med. 2010;3:47\u201357.","journal-title":"Int J Gen Med"},{"key":"1343_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20071733","volume":"20","author":"K Yamauchi","year":"2019","unstructured":"Yamauchi K, Ogasawara M. The role of histamine in the pathophysiology of asthma and the clinical efficacy of antihistamines in asthma therapy. Int J Mol Sci. 2019;20:1\u201316.","journal-title":"Int J Mol Sci"},{"key":"1343_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.pupt.2007.06.007","volume":"21","author":"MR Corboz","year":"2008","unstructured":"Corboz MR, Rivelli MA, Mingo GG, McLeod RL, Varty L, Jia Y, et al. Mechanism of decongestant activity of alpha 2-adrenoceptor agonists. Pulm Pharmacol Ther. 2008;21:449\u201354.","journal-title":"Pulm Pharmacol Ther"},{"key":"1343_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0735-6757(96)90119-9","volume":"14","author":"BE Bleske","year":"1996","unstructured":"Bleske BE, Rice TL, Warren EW, Giacherio DA, Gilligan LJ, Massey KD, et al. Effect of dose on the nasal absorption of epinephrine during cardiopulmonary resuscitation. Am J Emerg Med. 1996;14:133\u20138.","journal-title":"Am J Emerg Med"},{"key":"1343_CR26","volume-title":"Guide for the care and use of laboratory animals, 8th edition","author":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, Division on Earth and Life Studies, National Research Council of the National Academies","year":"2011","unstructured":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, Division on Earth and Life Studies, National Research Council of the National Academies. Guide for the care and use of laboratory animals, 8th edition. Washington, DC: National Academic Press; 2011."},{"key":"1343_CR27","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1152\/japplphysiol.00930.2002","volume":"94","author":"RL Tiniakov","year":"2003","unstructured":"Tiniakov RL, Tiniakova OP, McLeod RL, Hey JA, Yeates DB. Canine model of nasal congestion and allergic rhinitis. J Appl Physiol (1985). 2003;94:1821\u20138.","journal-title":"J Appl Physiol (1985)"},{"key":"1343_CR28","volume-title":"Pharmacokinetic analysis of intranasal epinephrine in dogs, submitted","author":"KL Dretchen","year":"2019","unstructured":"Dretchen KL, Mesa Z, Robben M, Slade D, Hill S, Croutch C, et al. Pharmacokinetic analysis of intranasal epinephrine in dogs, submitted. 2019."},{"key":"1343_CR29","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/S0196-0644(05)80657-2","volume":"21","author":"BE Bleske","year":"1992","unstructured":"Bleske BE, Warren EW, Rice TL, Shea MJ, Amidon G, Knight P. Comparison of intravenous and intranasal administration of epinephrine during CPR in a canine model. Ann Emerg Med. 1992;21:1125\u201330.","journal-title":"Ann Emerg Med"},{"key":"1343_CR30","first-page":"38","volume":"34","author":"C Srisawat","year":"2016","unstructured":"Srisawat C, Nakponetong K, Benjasupattananun P, Suratannon C, Wachirutmanggur L, Boonchoo S, et al. A preliminary study of intranasal epinephrine administration as a potential route for anaphylaxis treatment. Asian Pac J Allergy Immunol. 2016;34:38\u201343.","journal-title":"Asian Pac J Allergy Immunol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01343-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-020-01343-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01343-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T23:28:16Z","timestamp":1617406096000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-01343-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-01343-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"assertion":[{"value":"10 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}